131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma

被引：2
|
作者：
Castro, Gabriel [1 ]
Berrocal, Isabel [1 ]
Carmona, Jaime [1 ]
Gonzalez, Javiera [1 ]
Gonzalez, Patricio [1 ]
机构：
[1] Univ Chile, Clin Hosp, Nucl Med Sect, Independencia, Santiago De Chi, Chile
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷 / 08期
关键词：
Omeprazole; Differentiate Thyroid Cancer; Differentiate Thyroid Carcinoma; Radioiodine Therapy; Visual Score;
D O I：
10.1007/s00259-012-2104-1
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1356 / 1357
页数：2
相关论文
共 50 条
  • [31] Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma
    Koong, SS
    Reynolds, JC
    Movius, EG
    Keenan, AM
    Ain, KB
    Lakshmanan, MC
    Robbins, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03): : 912 - 916
  • [32] The effects assessment of 131I radioiodine therapy in patients with autonomously functioning thyroid nodules
    Adamczewski, Z.
    Kusmierek, J.
    Makarewicz, J.
    Jarek, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S278 - S278
  • [33] Assessment of the results of 131I radioiodine therapy in patients with autonomously functioning thyroid nodules
    Adamczewski, Z.
    Makarewicz, J.
    Kusmierek, J.
    Adamczewska, M.
    Jarek, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S654 - S654
  • [34] Two or three weeks of thyroid hormone withdrawal before initial 131I therapy for patients with differentiated thyroid carcinoma?
    Wang, Yueqi
    Huang, Shuhui
    Huang, Rui
    BMC CANCER, 2025, 25 (01)
  • [35] Prescribed Activity of 131I Therapy in Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) : 697 - 699
  • [36] Ultrasonography Echotexture as a surrogate for Sialadenitis secondary to 131I Radioiodine Therapy for differentiated Thyroid Cancer: a review and metaanalysis
    Simoes Lima, Graziele Aparecida
    Mendoza Lopez, Rossana Veronica
    Ozorio, Gislaine Aparecida
    Costa de Freitas, Ricardo Miguel
    Willegaignon, Jose
    Sapienza, Marcelo Tatit
    Chammas, Maria Christina
    Coura-Filho, George Barberio
    CLINICS, 2020, 75
  • [37] Incremental Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma
    Chen, Libo
    Luo, Quanyong
    Shen, Yan
    Yu, Yongli
    Yuan, Zhibin
    Lu, Hankui
    Zhu, Ruisen
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (12) : 1952 - 1957
  • [38] 131I SPECT/CT in the Follow-Up of Patients With Differentiated Thyroid Carcinoma
    Menges, Mareen
    Uder, Michael
    Kuwert, Torsten
    Schmidt, Daniela
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) : 555 - 560
  • [39] Additional Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma
    Marini, I.
    Maussier, M.
    Perotti, G.
    Salvatori, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S72 - S72
  • [40] UPTAKE OF 131I IN HOUSEHOLDS OF THYROID CANCER PATIENTS
    North, David L.
    HEALTH PHYSICS, 2013, 104 (04): : 434 - 436
12345